Acesso livre
Acesso livre

Hematologia Geral

Revisão | Reações à transfusão sanguínea.

29 Ago, 2022 | 13:38h

Blood Transfusion Reactions—A Comprehensive Review of the Literature including a Swiss Perspective – Journal of Clinical Medicine

 

Estudo de braço único fase 2 | Segurança e eficácia do mitapivate, ativador oral da piruvatequinase, em adultos com alfatalassemia ou betatalassemia não dependente de transfusão.

22 Ago, 2022 | 16:28h

Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study – The Lancet (link para o resumo – $ para o texto completo)

Comentário: PK Modulator Shows Promise in Thalassemia — In small study, mitapivat increased hemoglobin in 80% of non-transfusion-dependent patients – MedPage Today (necessário cadastro gratuito)

 

Diretriz | Uso de plasma convalescente de COVID-19.

22 Ago, 2022 | 16:08h

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma – Annals of Internal Medicine

Editorial: The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma – Annals of Internal Medicine

Comunicado de imprensa: The AABB releases clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma – American College of Physicians

 

M-A | Eficácia e segurança da anticoagulação com heparina em dose plena em pacientes de COVID-19 internados e não críticos.

16 Ago, 2022 | 13:04h

Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials – Journal of Thrombosis and Thrombolysis

Conteúdos relacionados:

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis – Open Forum Infectious Diseases

Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week – Journal of the American College of Cardiology

Point/Counterpoint: Should therapeutic heparin be administered to acutely ill hospitalized patients with COVID-19?

 

Revisão | Plasmaférese na UTI.

16 Ago, 2022 | 12:58h

Plasma exchange in the intensive care unit: a narrative review – Intensive Care Medicine

 

Comentário no Twitter

 

Diretriz de consenso | Tromboprofilaxia para prevenção de tromboembolismo venoso em pacientes internados com cirrose.

15 Ago, 2022 | 13:34h

Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH – Journal of Thrombosis and Haemostasis

 

Revisão | Microangiopatia trombótica em crianças.

9 Ago, 2022 | 16:35h

Thrombotic microangiopathy in children – Pediatric Nephrology (se o acesso a este link for pago, tente este)

 

Estudo de coorte | Incidência de síndrome torácica aguda em crianças com doença falciforme após implementação da vacina pneumocócica conjugada 13-valente.

5 Ago, 2022 | 16:06h

Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Following Implementation of the 13-Valent Pneumococcal Conjugate Vaccine in France – JAMA Network Open

 

Comentário no Twitter

 

Revisão sistemática | Transplante de células-tronco para esclerose sistêmica.

2 Ago, 2022 | 13:10h

Stem cell transplantation for systemic sclerosis – Cochrane Library

Resumo: Stem cell transplantation for the treatment of systemic sclerosis – Cochrane Library

 

M-A | Suplementação oral de ferro em pacientes com insuficiência cardíaca.

14 Jul, 2022 | 11:37h

Oral iron supplementation in patients with heart failure: a systematic review and meta-analysis – ESC Heart Failure

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.